Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.

Last verified: May 28, 2026 · Coverage navigation, not medical or financial advice · Sources: CMS, Medicare.gov, KFF

Medicare GLP-1 Bridge Part D Coverage Gap: Which Lane Are You In?

By The RX Index Editorial TeamUpdated May 28, 2026Editorial Standards

Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.

If you searched “Medicare GLP-1 Bridge Part D coverage gap,” here’s the short version: the old Part D “donut hole” is gone, but a different gap took its place — a routing gap. In 2026, getting a GLP-1 covered by Medicare isn’t really about whether you qualify. It’s about which lane your prescription belongs in. There are four. Pick the right one and you might pay $50 a month flat. Pick the wrong one and you could get denied — or pay full price for something Medicare would have covered.

Most people aren’t confused about GLP-1s. They’re confused about which door to walk through. This page is the map.

Bottom line

If your GLP-1 is prescribed for a condition Medicare already covers — type 2 diabetes; Wegovy® to reduce the risk of major heart problems in adults with established cardiovascular disease and obesity or overweight; or Zepbound® for moderate-to-severe obstructive sleep apnea in adults with obesity — it goes through regular Part D, and what you pay counts toward your 2026 out-of-pocket cap.

If it’s prescribed for weight loss and you meet the rules, it may go through the Medicare GLP-1 Bridge — a flat $50 a month, starting July 1, 2026, with no deductible step. But that $50 doesn’t count toward your cap, and Extra Help won’t lower it. Same drug, different reason, completely different rules.

Not sure which lane is yours? Find My GLP-1 Path →

Free, 60 seconds, no sign-up. We'll point you to the right lane and the exact words to bring your doctor.

What we actually verified

What	Source	Checked
Bridge dates, $50 copay, $245 net price, eligibility, covered drugs	CMS Medicare GLP-1 Bridge	May 28, 2026
$50 copay doesn't count toward cap; Extra Help doesn't apply	CMS Bridge FAQ	May 28, 2026
BIN 028918, PCN MEDDGLP1BR, SS&C Health / RelayHealth, effective 7/1/2026	CMS Payer Sheet (3/16/2026)	May 28, 2026
2026 Part D: $615 max deductible, $2,100 cap, donut hole eliminated 2025	Medicare.gov / NCOA	May 28, 2026
Wegovy CV indication; Zepbound OSA indication; Foundayo weight-management approval	U.S. FDA	May 28, 2026
Cash-price range $149–$699/month	KFF Health News	May 28, 2026
Ro pricing & government-plan policy	Ro pricing pages	May 28, 2026

Your four Medicare GLP-1 lanes, at a glance

For the Medicare GLP-1 coverage-gap question, there are four practical lanes. The lane depends on why the drug is prescribed and which drug it is — not on how badly you want it.

Your situation	Your lane	The one thing to know
GLP-1 for type 2 diabetes, Wegovy for cardiovascular risk reduction, or Zepbound for moderate-to-severe sleep apnea	Regular Part D	Your cost counts toward the $2,100 cap, and Extra Help can lower it.
GLP-1 for weight loss only, and you meet the BMI rules	Medicare GLP-1 Bridge	$50/month flat (any dose), starting July 1, 2026 — but it sits outside Part D.
Your plan denied your GLP-1	Appeal or reroute	The denial may be right — or the request may have gone to the wrong place.
You don't qualify, or need a drug before July 1	Cash-pay backup	Real, but pricier — and not part of Medicare.

Most of the heartburn online comes from people stuck between lane one and lane two. Let’s clear that up — but first, the donut hole.

Does Medicare have a GLP-1 Bridge Part D coverage gap in 2026?

Yes — but it’s not the famous “donut hole.” That coverage gap was eliminated on January 1, 2025. In 2026, Medicare Part D has three stages, and once your out-of-pocket spending on covered drugs reaches $2,100, you pay $0 for the rest of the year. The real GLP-1 “gap” today is about which payment path applies to your prescription.

Here’s what 2026 Part D looks like now:

Deductible stage

You pay full price until you've spent up to your plan's deductible. No plan can charge more than $615 in 2026.

Initial coverage stage

You pay copays or coinsurance until your out-of-pocket total hits $2,100.

Catastrophic stage

You pay $0 for covered drugs the rest of the year. The donut hole is gone.

So if someone tells you “watch out for the donut hole on your Ozempic,” they’re working off old information. The gap that actually trips people up now is the one in the search box: the gap between regular Part D coverage and the new $50 Bridge. They look similar. They follow completely different rules. And sending your prescription down the wrong one is the #1 reason people get stuck.

Which “coverage gap” do you actually mean?

People type “Medicare GLP-1 coverage gap” to mean at least five different problems. Naming yours is half the battle, because the fix is different for each one.

✅ The donut hole

Gone since 2025. If this was your worry, breathe — it doesn't exist anymore. Your real question is probably one of the four below.

→ Medicare won't cover it for weight loss

True for regular Part D. By law, standard Part D can't cover a drug used only for weight loss. That's exactly the gap the Bridge was built to fill.

→ My plan denied it

Could be the right call, could be a paperwork problem. Denial triage is its own section below.

→ The Bridge doesn't start until July 1

Real timing gap. If you need a drug now, you have options — just not free ones.

→ What happens after 2027?

The Bridge ends December 31, 2027. There's no guaranteed Medicare path after that yet. We cover the honest uncertainty later.

Should your GLP-1 go through regular Part D or the $50 Bridge?

Use regular Part D when your GLP-1 is prescribed for a condition Medicare already covers — type 2 diabetes, Wegovy for cardiovascular risk reduction, or Zepbound for moderate-to-severe sleep apnea. Use the Medicare GLP-1 Bridge only when the drug is prescribed for weight loss and you meet the Bridge’s rules. CMS is clear: if your use is already coverable under Part D, you can’t use the Bridge for it.

This is the fork in the road. Same drug — say, Wegovy — can go down either lane depending on why your doctor wrote it.

Go through Regular Part D if for:

✓Type 2 diabetes (Ozempic, Mounjaro, Rybelsus, others)
✓Wegovy to reduce cardiovascular risk in adults with established heart disease and obesity
✓Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity

Cost counts toward your $2,100 cap. Extra Help can lower it.

Go through the Bridge if for:

✓Weight loss and weight maintenance using Foundayo, Wegovy (shot or tablet), or the Zepbound KwikPen
✓You meet the clinical rules (BMI and condition criteria, next section)

$50/month flat, any dose — but sits outside Part D. Doesn’t count toward your cap.

Here’s the side-by-side that ends the confusion:

Question	Regular Part D	Medicare GLP-1 Bridge
Who runs it?	Your Part D or Medicare Advantage drug plan	CMS, through Humana (LI NET administrator)
What's it for?	Diabetes, cardiovascular risk, sleep apnea, other covered uses	Weight loss / weight maintenance only
What you pay	Your plan's deductible/copay (varies)	$50/month flat, any dose, any Part D phase
Counts toward $2,100 cap?	✅ Yes (if covered drug)	❌ No
Can Extra Help lower it?	✅ Yes	❌ No
Coupons allowed?	Usually blocked for Medicare	❌ No

What counts toward the $2,100 Part D cap?

Payment	Counts toward your $2,100 cap?
Regular Part D copay/coinsurance on a covered drug	✅ Yes
Extra Help (LIS) reduced cost share on a covered Part D drug	✅ Yes
Medicare GLP-1 Bridge $50 copay	❌ No
Manufacturer coupon (when allowed)	No (and rarely allowed on Medicare anyway)
Cash-pay purchase outside Medicare (e.g., a telehealth provider)	❌ No

The wrong-door trap: If your doctor sends a weight-loss Bridge request to your Part D plan, the plan may bounce it — and CMS says plans should then point your provider to the central processor instead. That round-trip is where people lose weeks. The fix is making sure the request goes to the right place the first time.

Want to walk in prepared? Get my doctor + pharmacy script →

We turn your situation into the exact words to say so the request lands in the right lane.

Who qualifies for the $50 Medicare GLP-1 Bridge?

You need to be enrolled in a Medicare Part D or Medicare Advantage drug plan, and your prescriber must confirm you meet one of three BMI-based clinical paths, with the medication prescribed for weight reduction alongside an ongoing lifestyle plan. BMI is judged at the time you started GLP-1 therapy — not the day the paperwork is filed.

Step 1 — the right kind of plan

You must be enrolled in 2026 in a standalone Part D drug plan (PDP) or a Medicare Advantage plan that includes drug coverage (MA-PD: HMO, HMOPOS, or local/regional PPO). Special Needs Plans, employer/union group plans, and the LI NET program also count. People in private fee-for-service plans, cost-contract plans, PACE, fallback plans, and a few others are not eligible unless they also have a standalone Part D plan.

Step 2 — one of three clinical paths

Your prescriber attests that, at the time you started GLP-1 therapy, you were 18 or older and met one of these:

Path	BMI at the time you started the GLP-1	Plus a qualifying condition?
Path 1	35 or higher	None needed
Path 2	30 or higher	Heart failure with preserved ejection fraction; uncontrolled high blood pressure (above 140/90 despite two medications); or chronic kidney disease stage 3a or worse
Path 3	27 or higher	Prediabetes; a past heart attack; a past stroke; or symptomatic peripheral artery disease

Step 3 — the lifestyle piece

The prescription has to be for reducing and maintaining weight along with ongoing nutrition and physical-activity changes, matching the drug’s FDA label.

Documents to bring to your prescriber, by path

Your path	What proves it
Path 1 (BMI ≥35)	Height and weight record from the date you started the GLP-1
Path 2 (BMI ≥30 + condition)	Starting height/weight + diagnosis records for HFpEF, hypertension (with two-medication history), or CKD stage 3a+
Path 3 (BMI ≥27 + condition)	Starting height/weight + diagnosis records for prediabetes, prior MI, prior stroke, or symptomatic peripheral artery disease
All paths	Medicare/Part D card; exact medication and formulation; documentation of an ongoing nutrition and activity plan

The detail that saves a lot of people: What if you already lost weight on a GLP-1 and your BMI dropped below the cutoff? You can still qualify. CMS judges your BMI at the time you first started the medication. If you began at a BMI of 37 and you’re at 34 today, your doctor attests you met the BMI-35 rule when therapy began. Don’t disqualify yourself because the scale moved — that’s the program working as intended.

The big three questions real people ask: “Does the $50 count toward my deductible?” (no — see below); “Can I use Extra Help to make it cheaper?” (no — also below); and “My doctor doesn’t know where to send it.” (the scripts section fixes that.) If you’ve asked any of these, you’re in the right place — the rules genuinely are confusing.

Which drugs does the Bridge cover — and which does it skip?

The Bridge covers all forms of Foundayo, all forms of Wegovy (shot and tablet), and the Zepbound KwikPen — but not the Zepbound single-dose vial or single-dose pen, and not Ozempic, Mounjaro, or Rybelsus. Compounded GLP-1s are not part of the program at all.

Medication	On the Bridge?	Can regular Part D cover it?	Note
Foundayo (orforglipron, a daily GLP-1 pill)	✅ Yes, all forms	Possibly, for future covered uses	FDA-approved for chronic weight management; added April 6, 2026
Wegovy (semaglutide, shot or tablet)	✅ Yes, all forms	Yes, for cardiovascular risk reduction	Two lanes — depends on why it's prescribed
Zepbound KwikPen (tirzepatide)	✅ Yes	Yes, for moderate-to-severe sleep apnea	Only the KwikPen counts for the Bridge
Zepbound vial / single-dose pen	❌ No	Possibly, for sleep apnea	Bridge skips these forms
Ozempic / Mounjaro / Rybelsus	❌ No	Yes, for diabetes	These stay in the Part D / diabetes lane
Compounded semaglutide or tirzepatide	❌ No	No standard Medicare lane	Not FDA-approved; payer sheet: “Compounds not allowed”

On compounded GLP-1s: they are not FDA-approved finished drugs, and the Bridge payer sheet states “Compounds not allowed.” This guide does not treat compounded GLP-1s as a standard Medicare route. If a website tells you it can get you a “Medicare-covered compounded GLP-1,” that’s a red flag.

What does the $50 copay actually count toward? (The honest catch.)

The $50 Bridge copay buys real access at a great price — but it lives outside your Part D plan. It does not count toward your $2,100 out-of-pocket cap, it does not count toward your deductible, Extra Help can’t reduce it, and you can’t stack a manufacturer coupon on top. Behind the scenes, drugmakers supply each month’s medication at a $245 net price, and none of that touches your Part D totals either.

Here’s the one drawback, said plainly, because you deserve to know it before you act:

The $50 Bridge copay is NOT normal Part D coverage

It does not count toward your $2,100 Part D cap. It also won’t help if your GLP-1 is one Part D already covers, and if you get Extra Help, that subsidy can’t shrink the $50.

Now the part that turns that catch into good news: for most people who qualify, $50 a month — flat, at any dose, in any phase of your Part D benefit — is still dramatically cheaper than every other path. KFF Health News reports current cash prices typically range from roughly $149 to $699 a month. The Bridge replaces all of that with one predictable $50, and it doesn’t climb when your dose climbs. So:

⚠

The Bridge does NOT count toward your Part D cap

If your only goal is to reach that $2,100 ceiling fast, that's a real downside. But because the Bridge skips the Part D payment flow and gives you a flat $50 that doesn't change by dose or Part D phase, for pure monthly cost most people come out ahead.

→

If counting toward your cap genuinely matters more

Say, you have a covered diagnosis and high overall drug spending — then standard Part D is your better lane, not the Bridge.

That’s the trade in plain terms. No spin. For the typical reader who wants a GLP-1 for weight loss and qualifies, the Bridge is the move.

Want to know which lane saves you the most? →

We compare your situation against Bridge, Part D, and backup options — no sign-up, no pressure.

When the Bridge is NOT your cheapest option

Skip the Bridge and use regular Part D when your GLP-1 is for a covered condition (diabetes, cardiovascular risk, sleep apnea) — especially if you have Extra Help. In those cases your cost counts toward the $2,100 cap and the subsidy can lower it, which the Bridge can’t do.

You have a condition Medicare already covers

If your doctor can prescribe a GLP-1 for type 2 diabetes, cardiovascular risk reduction (Wegovy), or moderate-to-severe sleep apnea (Zepbound), that's a Part D prescription. Your cost counts toward your cap. Once you hit $2,100, you pay $0 for covered drugs the rest of the year. The Bridge's flat $50 never gets you to that finish line.

You get Extra Help (the low-income subsidy)

Extra Help can drop your covered-drug costs to a few dollars per fill — but it cannot be applied to the Bridge's $50. If you have a covered diagnosis and Extra Help, your subsidized Part D price may well beat $50.

If either is you, your move is a Part D coverage request or appeal — not the Bridge. Don’t let a headline about “$50 GLP-1s” push you out of better coverage you already have. Check our Medicare GLP-1 eligibility guide to confirm which path actually wins for your situation.

What if your Part D plan already denied your GLP-1?

A denial isn’t the end — but the right next step depends on why you were denied. Match the wording on your letter to one of the common reasons below, then take the matching action. The Bridge does not erase your normal Part D appeal rights.

Pull out the denial letter and find your language:

What the denial says	What it usually means	Your next move
Excluded for weight loss	Standard Part D can't cover weight-loss-only use	Check Bridge eligibility — this is exactly its lane
Prior authorization required	The plan wants more documentation	Ask your prescriber to resubmit with your diagnosis, labs, and history
Not on formulary	The drug isn't on your plan's list	Ask about a formulary exception or a covered alternative
Not medically necessary	The paperwork didn't meet the plan's criteria	Ask your doctor to add the missing proof (BMI, sleep study, heart history)
Can't process this drug	A Bridge drug may have been sent to the plan	Ask whether it should go to the central processor instead

Two things worth knowing. First, “prior authorization” just means the plan wants your doctor to justify the prescription before it’s covered — it’s a form, not a wall. Second, the Bridge doesn’t change your right to appeal a Part D decision or request an exception. If your drug genuinely belongs in Part D, the appeal path stays fully open.

What should you bring to your doctor and pharmacy?

Bring your Medicare/Part D card, the exact drug and form you want, the reason it’s being prescribed, your starting BMI, any qualifying diagnoses, and any denial letter. The single most useful question you can ask: “Should this go through my Part D plan or the Medicare GLP-1 Bridge?”

Bring to your doctor:

·Your Medicare and Part D (or Medicare Advantage) card
·The exact medication and form (for Zepbound, say "KwikPen" — it matters)
·Why you want it: weight loss, diabetes, cardiovascular risk, or sleep apnea
·Your height and your weight when you started (or want to start) the GLP-1
·Any qualifying conditions (prediabetes, past heart attack or stroke, kidney disease, and so on)
·Your denial letter, if you have one

Say this to your doctor:

“I’m trying to figure out whether this GLP-1 should go through my regular Part D plan or the new Medicare GLP-1 Bridge. It’s being prescribed for [weight loss / diabetes / cardiovascular risk / sleep apnea]. Can you document the reason, the exact drug and form, and send the request to the right place?”

Say this to your pharmacist:

“Is this being run through my regular Part D plan or the Medicare GLP-1 Bridge? If it’s a Bridge drug, can you confirm it’s being submitted to the Bridge, not my plan?”

For your pharmacist — the technical bit:

CMS published the Bridge payer sheet on March 16, 2026. Bridge claims run through a dedicated billing path:

BIN	028918
PCN	MEDDGLP1BR
Processed by	SS&C Health / RelayHealth
Effective	July 1, 2026
Help desk	844-673-0910
Submissions	Electronic only (NCPDP) — no paper claims, no reimbursements

Get my doctor + pharmacy script →

We turn your situation into the exact words so the request lands in the right lane.

What if you don’t qualify — or need a GLP-1 before July 1, 2026?

Your best backup depends on why you’re stuck. If it’s timing, waiting a few weeks for the $50 Bridge is usually the cheapest choice. If it’s a covered condition, pursue Part D or an appeal. If you simply don’t qualify and want to start now, a cash-pay, FDA-approved telehealth option exists — but it’s not Medicare, and it costs more.

If you qualify for the Bridge and the only thing standing between you and $50/month is a few weeks on the calendar, waiting is almost always the cheaper move.

If it's a timing problem

Wait for July 1 if your doctor says that's fine, or use your existing Part D coverage if your use is already covered.

If it's a Part D enrollment problem

You may need to add a drug plan. Talk to your State Health Insurance Assistance Program (SHIP) for free, unbiased help, or call 1-800-MEDICARE (1-800-633-4227). Watch the timing — going too long without drug coverage can trigger a late-enrollment penalty.

If you genuinely don't qualify and want to start now

A cash-pay, FDA-approved telehealth route is an option. You can also compare GLP-1 costs without insurance to see the full picture.

Cash-pay option — not the Medicare GLP-1 Bridge

Sponsored affiliate link. If you qualify for the $50 Bridge, that’s still your cheaper path.

If you’re outside the Bridge’s rules, can’t wait, or want to talk to a prescriber today, one option worth knowing is Ro — a telehealth provider that offers FDA-approved GLP-1s including Zepbound and Foundayo. Ro Body (sponsored affiliate link, opens in a new tab) membership is $39 for the first month, then as low as $74/month with an annual plan paid upfront (medication is priced separately).

Ro is cash-pay. By its own policy, it can’t help coordinate GLP-1 medication coverage for government insurance plans like Medicare — though depending on the plan, Medicare, Medicare Supplement, or TRICARE members can still pay out of pocket for certain cash-pay medication options.

See current Ro pricing and eligibility →

Cash-pay, FDA-approved options for people who don’t qualify for Medicare’s program.

Not sure which bucket you're in? Run the free path-finder →

Before you do anything else.

What happens after December 31, 2027?

The Bridge is temporary. It runs July 1, 2026 through December 31, 2027, and was extended to that date after the voluntary BALANCE Model did not move forward in Medicare for 2027. There is no guaranteed Medicare weight-loss-drug coverage path locked in after 2027 yet.

The Bridge was originally scheduled to run only through December 2026. CMS extended it through 2027 because the bigger program meant to take over — the BALANCE Model (Better Approaches to Lifestyle and Nutrition for Comprehensive Health) — did not launch in Medicare for 2027 after too few insurers volunteered by the spring deadline.

The Medicare GLP-1 timeline at a glance

Date	What happened — or will happen
Dec. 23, 2025	CMS announces the BALANCE Model and the Medicare GLP-1 Bridge
Apr. 1, 2026	FDA approves Foundayo (orforglipron) for chronic weight management
Apr. 6, 2026	CMS adds Foundayo to the Bridge drug list
Apr. 2026	BALANCE Model does not move forward in Medicare for 2027; Bridge extended through Dec. 31, 2027
Jul. 1, 2026	Medicare GLP-1 Bridge launches: $50/month for eligible beneficiaries
Jan. 1, 2027	Negotiated maximum fair price for Ozempic, Rybelsus, and Wegovy takes effect under Medicare Drug Price Negotiation
Dec. 31, 2027	Medicare GLP-1 Bridge currently scheduled to end
2028 and beyond	No guaranteed Medicare obesity-drug coverage path locked in yet

·Your $50 access is reliable through December 31, 2027.

·After that, it's genuinely uncertain. BALANCE could arrive, or another path, or a gap.

→Action: set a reminder to review your coverage during the fall 2027 open enrollment, and watch CMS for updates. If you start on the Bridge, have a conversation with your doctor about what happens to your treatment if the program ends.

How we researched this guide

This guide is built from primary sources — the official CMS Medicare GLP-1 Bridge program rules and payer sheet, Medicare.gov cost figures, and FDA drug approvals — with policy context from KFF and pricing from provider pages. We show what we checked and when, and we flag anything CMS hasn’t finalized.

We don’t rewrite other people’s summaries. Every number on this page traces back to a source you can check yourself:

·Bridge rules, dates, $50 copay, $245 net price, eligibility, covered drugs, BIN/PCN, processor, help desk: CMS Medicare GLP-1 Bridge page.
·Part D cost stages, $615 deductible, $2,100 cap, donut hole elimination: Medicare.gov.
·Drug approvals (Wegovy for cardiovascular risk, Zepbound for sleep apnea, Foundayo for weight management): U.S. FDA.
·Cash-price range: KFF Health News.
·Ro-specific pricing and policy: Ro pricing and how-it-works pages.

Update log

May 28, 2026: Published. Verified against CMS Bridge page, CMS payer sheet, Medicare.gov, FDA, KFF, and Ro.
Before July 1, 2026: Re-check CMS for the final prior-authorization implementation guidance.
Quarterly after launch: Re-verify drugs, prices, and the post-2027 picture.

Medicare GLP-1 Bridge FAQ

Is the Medicare GLP-1 Bridge part of Part D?

No. You must be enrolled in a Part D or Medicare Advantage drug plan to use it, but the Bridge runs outside the Part D benefit, with its own central processor handling approvals and payments.

Is the Bridge available nationwide?

Yes. CMS says the Medicare GLP-1 Bridge will be nationwide and available in all states and territories, but you still have to meet the plan-type, drug, indication, and clinical criteria.

Does the $50 Bridge copay count toward my Part D out-of-pocket maximum?

No. CMS confirms the $50 copay does not count toward your true out-of-pocket total (TrOOP) or your deductible. The $2,100 cap is unaffected by Bridge fills.

Can Extra Help lower the $50 Bridge copay?

No. Low-income subsidies don't apply to any part of the Bridge copay. If you have Extra Help and a covered diagnosis, standard Part D may actually be cheaper for you.

Can I use a manufacturer coupon with the Bridge?

No. Coupons and discount cards can't be applied to Bridge claims. The $50 is the price.

Can the Medicare Prescription Payment Plan help with GLP-1 costs?

The Medicare Prescription Payment Plan can help spread monthly costs for covered Part D drugs across the calendar year, but it doesn't lower the total. Because the Bridge operates outside Part D, don't assume Bridge copays can be spread through this plan.

Does Medicare drug price negotiation change the Bridge or Part D costs in 2027?

Ozempic, Rybelsus, and Wegovy have a negotiated maximum fair price that takes effect January 1, 2027 under the Medicare Drug Price Negotiation Program. CMS says the Medicare GLP-1 Bridge is a distinct, time-limited demonstration, and for 2026 the two programs operate independently.

Does Medicare cover GLP-1s for weight loss?

Standard Part D can't cover a drug used only for weight loss. The Medicare GLP-1 Bridge is the temporary path that makes weight-loss coverage possible for eligible people, at $50/month, starting July 1, 2026.

Does Medicare cover Wegovy or Zepbound?

It depends on why. For weight loss, eligible people can use the Bridge. For cardiovascular risk reduction (Wegovy) or moderate-to-severe sleep apnea (Zepbound), it goes through regular Part D instead.

Are Ozempic, Mounjaro, or Rybelsus on the Bridge?

No. The Bridge covers Foundayo, Wegovy, and the Zepbound KwikPen for weight loss. Ozempic, Mounjaro, and Rybelsus stay in the Part D / diabetes lane.

Do Medicare Advantage drug plans qualify?

Yes — most Medicare Advantage plans that include drug coverage (MA-PD) qualify, including HMO, HMOPOS, and local/regional PPO plans.

Does my doctor have to be enrolled in Medicare to prescribe a Bridge drug?

No. CMS says a provider does not need to be enrolled in Medicare to write a Bridge prescription or submit a prior authorization. The prescriber must not be on the CMS Preclusion List.

Do pharmacies have to opt in to the Bridge?

No. CMS says pharmacies don't need to opt in, but they must route Bridge claims correctly through the dedicated billing path (BIN 028918, PCN MEDDGLP1BR).

Can I submit a paper claim or get reimbursed later?

No. CMS says Bridge claims are submitted electronically through the NCPDP standard. Paper claims and direct member reimbursements are not accepted.

My BMI dropped after losing weight — can I still qualify?

Yes. Eligibility is based on your BMI when you started the GLP-1, not the day the request is filed.

Can a telehealth company like Ro get me the Medicare Bridge?

No. Cash-pay telehealth services can't coordinate Medicare coverage. They're a backup for people outside the program, not a Medicare path.

What happens after December 31, 2027?

The Bridge ends then, and there's no locked-in Medicare replacement yet. Plan to review your coverage at fall 2027 open enrollment and watch CMS for updates.

You don’t have to figure this out alone, and you definitely shouldn’t guess with a prescription on the line.

Take the free 60-second “Find My GLP-1 Path” quiz →

We’ll point you to the right lane — Part D, the $50 Bridge, an appeal, or a backup — and hand you the exact words to bring your doctor. No sign-up. No pressure.

Related guides

Sources

Disclosure: The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. Some links on this page are affiliate links, meaning we may earn a commission if you sign up — at no extra cost to you. This Medicare coverage guide is based on CMS, Medicare.gov, FDA, and KFF sources, and our coverage guidance is not influenced by those relationships. This page is for education only and is not medical or financial advice. For personalized Medicare help, call 1-800-MEDICARE (1-800-633-4227) or contact your free State Health Insurance Assistance Program (SHIP). Last verified: May 28, 2026.